SARS-CoV-2 infection as a potential risk factor for the development of cancer

The COVID-19 pandemic has a significant impact on public health and the estimated number of excess deaths may be more than three times higher than documented in official statistics. Numerous studies have shown an increased risk of severe COVID-19 and death in patients with cancer. In addition, the r...

Full description

Bibliographic Details
Main Authors: Natalia Ogarek, Paulina Oboza, Magdalena Olszanecka-Glinianowicz, Piotr Kocelak
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1260776/full
_version_ 1797688838547570688
author Natalia Ogarek
Paulina Oboza
Magdalena Olszanecka-Glinianowicz
Piotr Kocelak
author_facet Natalia Ogarek
Paulina Oboza
Magdalena Olszanecka-Glinianowicz
Piotr Kocelak
author_sort Natalia Ogarek
collection DOAJ
description The COVID-19 pandemic has a significant impact on public health and the estimated number of excess deaths may be more than three times higher than documented in official statistics. Numerous studies have shown an increased risk of severe COVID-19 and death in patients with cancer. In addition, the role of SARS-CoV-2 as a potential risk factor for the development of cancer has been considered. Therefore, in this review, we summarise the available data on the potential effects of SARS-CoV-2 infection on oncogenesis, including but not limited to effects on host signal transduction pathways, immune surveillance, chronic inflammation, oxidative stress, cell cycle dysregulation, potential viral genome integration, epigenetic alterations and genetic mutations, oncolytic effects and reactivation of dormant cancer cells. We also investigated the potential long-term effects and impact of the antiviral therapy used in COVID-19 on cancer development and its progression.
first_indexed 2024-03-12T01:37:23Z
format Article
id doaj.art-a162d16c009c42609b334adb12436e97
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-03-12T01:37:23Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-a162d16c009c42609b334adb12436e972023-09-11T05:35:49ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-09-011010.3389/fmolb.2023.12607761260776SARS-CoV-2 infection as a potential risk factor for the development of cancerNatalia Ogarek0Paulina Oboza1Magdalena Olszanecka-Glinianowicz2Piotr Kocelak3Pathophysiology Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, The Medical University of Silesia, Katowice, PolandStudents’ Scientific Society at the Pathophysiology Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, The Medical University of Silesia, Katowice, PolandHealth Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, The Medical University of Silesia, Katowice, PolandPathophysiology Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, The Medical University of Silesia, Katowice, PolandThe COVID-19 pandemic has a significant impact on public health and the estimated number of excess deaths may be more than three times higher than documented in official statistics. Numerous studies have shown an increased risk of severe COVID-19 and death in patients with cancer. In addition, the role of SARS-CoV-2 as a potential risk factor for the development of cancer has been considered. Therefore, in this review, we summarise the available data on the potential effects of SARS-CoV-2 infection on oncogenesis, including but not limited to effects on host signal transduction pathways, immune surveillance, chronic inflammation, oxidative stress, cell cycle dysregulation, potential viral genome integration, epigenetic alterations and genetic mutations, oncolytic effects and reactivation of dormant cancer cells. We also investigated the potential long-term effects and impact of the antiviral therapy used in COVID-19 on cancer development and its progression.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1260776/fullcancerexcess deathlong CovidoncogenesisSARS-CoV-2 infection
spellingShingle Natalia Ogarek
Paulina Oboza
Magdalena Olszanecka-Glinianowicz
Piotr Kocelak
SARS-CoV-2 infection as a potential risk factor for the development of cancer
Frontiers in Molecular Biosciences
cancer
excess death
long Covid
oncogenesis
SARS-CoV-2 infection
title SARS-CoV-2 infection as a potential risk factor for the development of cancer
title_full SARS-CoV-2 infection as a potential risk factor for the development of cancer
title_fullStr SARS-CoV-2 infection as a potential risk factor for the development of cancer
title_full_unstemmed SARS-CoV-2 infection as a potential risk factor for the development of cancer
title_short SARS-CoV-2 infection as a potential risk factor for the development of cancer
title_sort sars cov 2 infection as a potential risk factor for the development of cancer
topic cancer
excess death
long Covid
oncogenesis
SARS-CoV-2 infection
url https://www.frontiersin.org/articles/10.3389/fmolb.2023.1260776/full
work_keys_str_mv AT nataliaogarek sarscov2infectionasapotentialriskfactorforthedevelopmentofcancer
AT paulinaoboza sarscov2infectionasapotentialriskfactorforthedevelopmentofcancer
AT magdalenaolszaneckaglinianowicz sarscov2infectionasapotentialriskfactorforthedevelopmentofcancer
AT piotrkocelak sarscov2infectionasapotentialriskfactorforthedevelopmentofcancer